Lv1
40 积分 2024-06-26 加入
P-162 Preliminary results of the feasibility and tolerability of anlotinib plus PD-1 blockades among patients with previously immunotherapy treated advanced esophageal squamous cell carcinoma (ESCC): A retrospective exploratory study
16小时前
待确认
Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study
1个月前
已完结
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
1个月前
已完结
Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment
2个月前
已关闭
Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma
2个月前
已完结
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
2个月前
已完结
Clinical aspects of the using of clopheline in postoperative period in elderly patient with arterial hypertension
2个月前
已关闭
Advances in diagnosis and management of cancer of the esophagus
2个月前
已完结
Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial
3个月前
已完结
Synergism Between Immunotherapy and Radiotherapy in Esophageal Cancer: An Overview of Current Knowledge and Future Perspectives
5个月前
已完结
皖公网安备34019202002308
